医学
糖尿病
糖基化
疾病
生物信息学
阿尔茨海默病
氧化应激
药物开发
2型糖尿病
药品
内科学
内分泌学
药理学
生物
作者
Catrina Sims‐Robinson,Bhumsoo Kim,Andrew J. Rosko,Eva L. Feldman
标识
DOI:10.1038/nrneurol.2010.130
摘要
Diabetes and Alzheimer disease (AD)-two age-related diseases-are both increasing in prevalence, and numerous studies have demonstrated that patients with diabetes have an increased risk of developing AD compared with healthy individuals. The underlying biological mechanisms that link the development of diabetes with AD are not fully understood. Abnormal protein processing, abnormalities in insulin signaling, dysregulated glucose metabolism, oxidative stress, the formation of advanced glycation end products, and the activation of inflammatory pathways are features common to both diseases. Hypercholesterolemia is another factor that has received attention, owing to its potential association with diabetes and AD. This Review summarizes the mechanistic pathways that might link diabetes and AD. An understanding of this complex interaction is necessary for the development of novel drug therapies and lifestyle guidelines aimed at the treatment and/or prevention of these diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI